Basic Materials / Specialty ChemicalsBSE
$1124.60
+12.05 (+1.08%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-1.2B · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$26.4B
P/E
131.5x
↑EV/EBITDA
55.9x
↑ROE
2.5%
↑Gross Margin
30.6%
↑Debt/Equity
0.43
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+0.2%
FCF CAGR
—
FCF margin
-23.8%
FCF / Net income
-6.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.05B · net income $192.3M · FCF $-1.20B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.05B | $5.05B | $5.35B | $4.61B | $5.02B |
| Net Income | $192.3M | $192.3M | $380.0M | $438.8M | $453.6M |
| EBITDA | $498.5M | $498.5M | $691.2M | $753.7M | $769.5M |
| EPS | 8.45 | 8.45 | 17.01 | 21.77 | 24.35 |
| Gross Margin | 30.6% | 30.6% | 28.5% | 29.4% | 28.4% |
| Operating Margin | 7.0% | 7.0% | 7.8% | 12.4% | 12.5% |
| Net Margin | 3.8% | 3.8% | 7.1% | 9.5% | 9.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.43 | 0.43 | 0.44 | 0.07 | 0.17 |
| Current Ratio | 4.12 | 4.12 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.20B | $-1.20B | $-2.74B | $58.2M | $465.4M |
| Returns | |||||
| ROE | 2.5% | 2.5% | 6.2% | 7.8% | 19.4% |
| Valuation | |||||
| P/E | 131.53 | 131.53 | 67.78 | 50.16 | 27.84 |
| EV/EBITDA | 55.94 | 55.94 | 39.65 | 29.70 | 16.91 |
| P/B | 3.37 | 3.37 | 4.22 | 3.93 | 5.41 |
| Growth & Yield | |||||
| Revenue Growth | -5.6% | -5.6% | 16.1% | -8.2% | — |
| EPS Growth | -50.3% | -50.3% | -21.9% | -10.6% | — |
| Dividend Yield | 0.2% | 0.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
127.7%
EPS terminal req.
$99.79
Spread vs growth
-178.0%
5Y implied EPS CAGR
70.2%
EPS terminal req.
$120.75
Spread vs growth
-120.5%
10Y implied EPS CAGR
36.8%
EPS terminal req.
$194.46
Spread vs growth
-87.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-7.6%
Start / end P/E
71.7x → 133.1x
EPS bridge
17.01 → 8.45
Residual
-43.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.